Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.160
-0.030 (-2.52%)
At close: Jan 16, 2026, 4:00 PM EST
1.150
-0.010 (-0.84%)
After-hours: Jan 16, 2026, 7:05 PM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $10.51 million as of January 16, 2026. Its market cap has decreased by -27.79% in one year.
Market Cap
10.51M
Enterprise Value
11.69M
1-Year Change
-27.79%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $10.51M, a decrease of -82.05%. That is a compound annual growth rate of -33.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 10.51M | 3.57% |
| Dec 31, 2025 | 10.15M | -30.28% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
| Nov 5, 2021 | 58.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |